Genomic characterisation of pulmonary subsolid nodules: mutational landscape and radiological features
暂无分享,去创建一个
D. Shen | Ruoyan Li | F. Bai | K. Sun | Jun Wang | Fan Yang | Xiao Li | Yanmeng Li | Lientu Wang | Hao Li | Xiang Zhu | Taorui Liu | Qingyi Qi | Yifan Zhao | B. An | Ziyang Liu | J. Mi
[1] Yi-long Wu,et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early-Invasive Lung Adenocarcinoma. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[2] Xiaodong Yang,et al. Ground glass opacities: Imaging, pathology, and gene mutations , 2018, The Journal of thoracic and cardiovascular surgery.
[3] Y. Hua,et al. CT features differentiating pre- and minimally invasive from invasive adenocarcinoma appearing as mixed ground-glass nodules: mass is a potential imaging biomarker. , 2018, Clinical radiology.
[4] Steven J. M. Jones,et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. , 2018, Cell.
[5] K. Inamura. Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression , 2018, International journal of molecular sciences.
[6] Zaw Win Aung,et al. Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing , 2018, Nature Communications.
[7] D. Shen,et al. Early metastasis detected in patients with multifocal pulmonary ground-glass opacities (GGOs) , 2017, Thorax.
[8] Kenji Suzuki,et al. DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panel. , 2017, Lung cancer.
[9] A. Bankier,et al. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. , 2017, Radiology.
[10] I. Wistuba,et al. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] P. Brennan,et al. Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma , 2016, Scientific Reports.
[12] K. Ashizawa,et al. Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter Study , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[13] Chandra Sekhar Pedamallu,et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas , 2016, Nature Genetics.
[14] Xun Xu,et al. Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas , 2015, Nature Communications.
[15] Siân Jones,et al. Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA , 2015, Nature Communications.
[16] C. Swanton,et al. Analysis of intratumor heterogeneity unravels lung cancer evolution , 2015, Molecular & cellular oncology.
[17] Y. Yatabe,et al. Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] Z. Szallasi,et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.
[19] J. Gagné,et al. Germline mutations in BAP1 impair its function in DNA double-strand break repair. , 2014, Cancer research.
[20] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[21] T. Nagase,et al. SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability. , 2014, Cancer research.
[22] D. Higgs,et al. The chromatin remodeller ATRX: a repeat offender in human disease. , 2013, Trends in biochemical sciences.
[23] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[24] Angela N. Brooks,et al. Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.
[25] W. Nishio,et al. Survival of 1737 lobectomy-tolerable patients who underwent limited resection for cStage IA non-small-cell lung cancer. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[26] Guo-Min Li,et al. Mechanisms and functions of DNA mismatch repair , 2008, Cell Research.